US Stock MarketDetailed Quotes

HALO Halozyme Therapeutics

Watchlist
  • 45.480
  • -0.060-0.13%
Close May 22 16:00 ET
  • 45.000
  • -0.480-1.06%
Post 18:59 ET
5.79BMarket Cap18.87P/E (TTM)

Halozyme Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
48.83%129.43M
61.83%388.57M
24.14%102.35M
90.15%132.41M
66.17%66.84M
81.94%86.96M
-19.81%240.11M
-0.08%82.45M
-42.80%69.64M
9.04%40.23M
Net income from continuing operations
93.92%76.82M
39.31%281.59M
47.98%85.39M
32.78%81.84M
229.53%74.75M
-34.09%39.62M
-49.81%202.13M
-13.58%57.7M
-71.54%61.63M
-75.20%22.69M
Operating gains losses
---7K
-67.08%611K
91.84%94K
--0
----
----
--1.86M
--49K
--0
--1.73M
Depreciation and amortization
-1.23%20.21M
70.94%84.86M
190.88%20.69M
-20.97%23.08M
64.42%20.63M
2,529.43%20.46M
1,556.36%49.64M
820.31%7.11M
3,788.55%29.2M
1,606.94%12.55M
Deferred tax
-66.68%1.29M
-13.75%34.51M
-35.79%9.42M
-62.25%9.7M
186.53%11.51M
-70.03%3.87M
125.74%40.01M
213.30%14.68M
118.04%25.7M
---13.3M
Other non cash items
-4.87%2.05M
-166.78%-4.63M
777.43%5.68M
-313.02%-12.17M
-203.25%-286K
645.67%2.16M
-69.01%6.93M
125.44%647K
1,919.08%5.71M
-2.46%277K
Change In working capital
56.04%21.56M
55.01%-38.67M
-413.80%-26.1M
137.06%22.09M
-566.37%-48.48M
143.62%13.81M
-2,399.38%-85.95M
-123.33%-5.08M
-246.70%-59.6M
116.89%10.39M
-Change in receivables
5.86%38.31M
96.02%-3.34M
-117.73%-16.89M
165.67%28.85M
-444.07%-51.5M
258.81%36.19M
-1,342.65%-83.94M
-136.71%-7.76M
-206.90%-43.93M
85.39%-9.47M
-Change in inventory
-454.94%-40.23M
-53.79%-26.88M
149.88%1.47M
165.94%3.63M
-61.44%-24.74M
-215.12%-7.25M
-337.16%-17.48M
-232.72%-2.95M
-302.24%-5.51M
-17,717.44%-15.32M
-Change in prepaid assets
-46.01%4.8M
145.21%4.1M
-122.68%-1.2M
-67.66%-8.45M
3,323.84%4.87M
196.87%8.88M
21.56%-9.06M
205.02%5.3M
-639.00%-5.04M
95.68%-151K
-Change in payables and accrued expense
177.83%18.69M
-151.14%-12.55M
-3,007.67%-9.48M
61.85%-1.95M
-35.22%22.89M
-299.43%-24.01M
2,002.40%24.54M
-90.61%326K
-103.50%-5.11M
417.09%35.33M
Cash from discontinued investing activities
Operating cash flow
48.83%129.43M
61.83%388.57M
24.14%102.35M
90.15%132.41M
66.17%66.84M
81.94%86.96M
-19.81%240.11M
-0.08%82.45M
-42.80%69.64M
9.04%40.23M
Investing cash flow
Cash flow from continuing investing activities
-37.43%-82.68M
80.10%-96.91M
-374.86%-8.29M
-8,178.77%-83.45M
112.64%54.99M
-22.02%-60.16M
-19.87%-487.01M
99.42%-1.75M
94.05%-1.01M
-874.87%-434.95M
Net PPE purchase and sale
68.84%-3.55M
-217.96%-15.29M
-10.75%-2.6M
-192.06%-2.94M
267.67%1.62M
-2,221.84%-11.38M
-230.13%-4.81M
-1,383.54%-2.34M
-103.23%-1.01M
-81.61%-968K
Net business purchase and sale
----
--0
--0
--0
----
----
---999.12M
--0
--0
----
Net investment purchase and sale
-62.21%-79.14M
-116.62%-81.62M
39.33%-5.7M
---80.51M
-90.28%53.37M
0.06%-48.79M
221.26%490.92M
96.86%-9.39M
--0
1,345.65%549.12M
Net other investing changes
----
----
----
----
----
----
--26.01M
--9.99M
--0
----
Cash from discontinued investing activities
Investing cash flow
-37.43%-82.68M
80.10%-96.91M
-374.86%-8.29M
-8,178.77%-83.45M
112.64%54.99M
-22.02%-60.16M
-19.87%-487.01M
99.42%-1.75M
94.05%-1.01M
-874.87%-434.95M
Financing cash flow
Cash flow from continuing financing activities
99.70%-489K
-212.59%-407.99M
-4,048.81%-249.92M
133.07%4.1M
-99.33%2.45M
-26,480.45%-164.61M
365.38%362.37M
104.06%6.33M
79.36%-12.4M
921.81%367.82M
Net issuance payments of debt
--0
-102.16%-13.48M
--0
--0
--0
---13.48M
50.20%624.55M
--0
--254.55M
--370M
Net common stock issuance
--0
-101.19%-402.38M
-25,229,900.00%-252.3M
--0
--0
---150.08M
42.87%-200M
100.00%-1K
-209.04%-200M
--0
Proceeds from stock option exercised by employees
53.34%-489K
-43.92%7.88M
-65.85%2.38M
55.58%4.1M
-35.99%2.45M
-267.95%-1.05M
12.08%14.05M
61.69%6.97M
-43.29%2.64M
-8.59%3.82M
Net other financing activities
----
----
----
----
----
----
-17,877.36%-76.22M
---639K
---69.58M
----
Cash from discontinued financing activities
Financing cash flow
99.70%-489K
-212.59%-407.99M
-4,048.81%-249.92M
133.07%4.1M
-99.33%2.45M
-26,480.45%-164.61M
365.38%362.37M
104.06%6.33M
79.36%-12.4M
921.81%367.82M
Net cash flow
Beginning cash position
-49.56%118.37M
96.86%234.7M
85.72%274.23M
141.89%221.17M
-18.13%96.88M
96.86%234.7M
-19.56%119.22M
-70.00%147.66M
-79.57%91.43M
-76.33%118.34M
Current changes in cash
133.57%46.26M
-200.74%-116.33M
-279.07%-155.86M
-5.63%53.06M
561.96%124.28M
-15,489.59%-137.81M
498.41%115.48M
123.34%87.04M
25.74%56.23M
48.74%-26.9M
End cash Position
69.92%164.63M
-49.56%118.37M
-49.56%118.37M
85.72%274.23M
141.89%221.17M
-18.13%96.88M
96.86%234.7M
96.86%234.7M
-70.00%147.66M
-79.57%91.43M
Free cash flow
66.54%125.88M
58.64%373.28M
24.53%99.76M
88.65%129.47M
74.40%68.47M
59.78%75.59M
-21.04%235.3M
-2.73%80.11M
-43.40%68.63M
7.98%39.26M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 48.83%129.43M61.83%388.57M24.14%102.35M90.15%132.41M66.17%66.84M81.94%86.96M-19.81%240.11M-0.08%82.45M-42.80%69.64M9.04%40.23M
Net income from continuing operations 93.92%76.82M39.31%281.59M47.98%85.39M32.78%81.84M229.53%74.75M-34.09%39.62M-49.81%202.13M-13.58%57.7M-71.54%61.63M-75.20%22.69M
Operating gains losses ---7K-67.08%611K91.84%94K--0----------1.86M--49K--0--1.73M
Depreciation and amortization -1.23%20.21M70.94%84.86M190.88%20.69M-20.97%23.08M64.42%20.63M2,529.43%20.46M1,556.36%49.64M820.31%7.11M3,788.55%29.2M1,606.94%12.55M
Deferred tax -66.68%1.29M-13.75%34.51M-35.79%9.42M-62.25%9.7M186.53%11.51M-70.03%3.87M125.74%40.01M213.30%14.68M118.04%25.7M---13.3M
Other non cash items -4.87%2.05M-166.78%-4.63M777.43%5.68M-313.02%-12.17M-203.25%-286K645.67%2.16M-69.01%6.93M125.44%647K1,919.08%5.71M-2.46%277K
Change In working capital 56.04%21.56M55.01%-38.67M-413.80%-26.1M137.06%22.09M-566.37%-48.48M143.62%13.81M-2,399.38%-85.95M-123.33%-5.08M-246.70%-59.6M116.89%10.39M
-Change in receivables 5.86%38.31M96.02%-3.34M-117.73%-16.89M165.67%28.85M-444.07%-51.5M258.81%36.19M-1,342.65%-83.94M-136.71%-7.76M-206.90%-43.93M85.39%-9.47M
-Change in inventory -454.94%-40.23M-53.79%-26.88M149.88%1.47M165.94%3.63M-61.44%-24.74M-215.12%-7.25M-337.16%-17.48M-232.72%-2.95M-302.24%-5.51M-17,717.44%-15.32M
-Change in prepaid assets -46.01%4.8M145.21%4.1M-122.68%-1.2M-67.66%-8.45M3,323.84%4.87M196.87%8.88M21.56%-9.06M205.02%5.3M-639.00%-5.04M95.68%-151K
-Change in payables and accrued expense 177.83%18.69M-151.14%-12.55M-3,007.67%-9.48M61.85%-1.95M-35.22%22.89M-299.43%-24.01M2,002.40%24.54M-90.61%326K-103.50%-5.11M417.09%35.33M
Cash from discontinued investing activities
Operating cash flow 48.83%129.43M61.83%388.57M24.14%102.35M90.15%132.41M66.17%66.84M81.94%86.96M-19.81%240.11M-0.08%82.45M-42.80%69.64M9.04%40.23M
Investing cash flow
Cash flow from continuing investing activities -37.43%-82.68M80.10%-96.91M-374.86%-8.29M-8,178.77%-83.45M112.64%54.99M-22.02%-60.16M-19.87%-487.01M99.42%-1.75M94.05%-1.01M-874.87%-434.95M
Net PPE purchase and sale 68.84%-3.55M-217.96%-15.29M-10.75%-2.6M-192.06%-2.94M267.67%1.62M-2,221.84%-11.38M-230.13%-4.81M-1,383.54%-2.34M-103.23%-1.01M-81.61%-968K
Net business purchase and sale ------0--0--0-----------999.12M--0--0----
Net investment purchase and sale -62.21%-79.14M-116.62%-81.62M39.33%-5.7M---80.51M-90.28%53.37M0.06%-48.79M221.26%490.92M96.86%-9.39M--01,345.65%549.12M
Net other investing changes --------------------------26.01M--9.99M--0----
Cash from discontinued investing activities
Investing cash flow -37.43%-82.68M80.10%-96.91M-374.86%-8.29M-8,178.77%-83.45M112.64%54.99M-22.02%-60.16M-19.87%-487.01M99.42%-1.75M94.05%-1.01M-874.87%-434.95M
Financing cash flow
Cash flow from continuing financing activities 99.70%-489K-212.59%-407.99M-4,048.81%-249.92M133.07%4.1M-99.33%2.45M-26,480.45%-164.61M365.38%362.37M104.06%6.33M79.36%-12.4M921.81%367.82M
Net issuance payments of debt --0-102.16%-13.48M--0--0--0---13.48M50.20%624.55M--0--254.55M--370M
Net common stock issuance --0-101.19%-402.38M-25,229,900.00%-252.3M--0--0---150.08M42.87%-200M100.00%-1K-209.04%-200M--0
Proceeds from stock option exercised by employees 53.34%-489K-43.92%7.88M-65.85%2.38M55.58%4.1M-35.99%2.45M-267.95%-1.05M12.08%14.05M61.69%6.97M-43.29%2.64M-8.59%3.82M
Net other financing activities -------------------------17,877.36%-76.22M---639K---69.58M----
Cash from discontinued financing activities
Financing cash flow 99.70%-489K-212.59%-407.99M-4,048.81%-249.92M133.07%4.1M-99.33%2.45M-26,480.45%-164.61M365.38%362.37M104.06%6.33M79.36%-12.4M921.81%367.82M
Net cash flow
Beginning cash position -49.56%118.37M96.86%234.7M85.72%274.23M141.89%221.17M-18.13%96.88M96.86%234.7M-19.56%119.22M-70.00%147.66M-79.57%91.43M-76.33%118.34M
Current changes in cash 133.57%46.26M-200.74%-116.33M-279.07%-155.86M-5.63%53.06M561.96%124.28M-15,489.59%-137.81M498.41%115.48M123.34%87.04M25.74%56.23M48.74%-26.9M
End cash Position 69.92%164.63M-49.56%118.37M-49.56%118.37M85.72%274.23M141.89%221.17M-18.13%96.88M96.86%234.7M96.86%234.7M-70.00%147.66M-79.57%91.43M
Free cash flow 66.54%125.88M58.64%373.28M24.53%99.76M88.65%129.47M74.40%68.47M59.78%75.59M-21.04%235.3M-2.73%80.11M-43.40%68.63M7.98%39.26M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion--------Unqualified Opinion------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg